Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Parasitol Int ; 67(5): 547-555, 2018 10.
Artigo em Inglês | MEDLINE | ID: mdl-29733902

RESUMO

Trypanosoma cruzi infection stimulates inflammatory mediators which cause oxidative stress, and the use of antioxidants can minimize the sequelae of Chagas disease. In order to evaluate the efficacy of vitamin C in minimizing oxidative damage in Chagas disease, we orally administered ascorbic acid to Swiss mice infected with 5.0 × 104 trypomastigote forms of T. cruzi QM2 strain. These animals were treated for 60 days to investigate the acute phase and 180 days for the chronic phase. During the acute phase, the animals in the infected and treated groups demonstrated lower parasitemia and inflammatory processes were seen in more mice in these groups, probably due to the higher concentration of nitric oxide, which led to the formation of peroxynitrite. The decrease in reduced glutathione concentration in this group showed a circulating oxidant state, and this antioxidant was used to regenerate vitamin C. During the chronic phase, the animals in the infected and treated group showed a decrease in ferric reducing ability of plasma and uric acid concentrations as well as mobilization of bilirubin (which had higher plasma concentration), demonstrating cooperation between endogenous non-enzymatic antioxidants to combat increased oxidative stress. However, lower ferrous oxidation in xylenol orange concentrations was found in the infected and treated group, suggesting that vitamin C provided biological protection by clearing the peroxynitrite, attenuating the chronic inflammatory process in the tissues and favoring greater survival in these animals. Complex interactions were observed between the antioxidant systems of the host and parasite, with paradoxical actions of vitamin C.


Assuntos
Antioxidantes/uso terapêutico , Ácido Ascórbico/uso terapêutico , Doença de Chagas/tratamento farmacológico , Inflamação/tratamento farmacológico , Doença Aguda , Animais , Ácido Ascórbico/efeitos adversos , Bilirrubina/sangue , Bilirrubina/metabolismo , Doença Crônica , Modelos Animais de Doenças , Ferro/metabolismo , Masculino , Camundongos , Óxido Nítrico/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Parasitemia/tratamento farmacológico , Ácido Peroxinitroso/metabolismo , Trypanosoma cruzi
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa